Purchases and Sales Made in Q3 2022 in Cytom X Therapeutics, Inc. (CTMX)
This table provides information about the institutional ownership of Cytom X Therapeutics, Inc. (CTMX) during Q3 2022. The information is specifically focused on institutions that hold shares of CytomX Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Xtx Topco LTD
London, X0 |
SELL
|
- |
-55.8K- 55.42% |
$68.6K - $110K
|
44.8K
$37.7K
|
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-146K- 90.67% |
$180K - $288K
|
15.1K
$12.6K
|
|
|
Nov 10, 2022
Q3 2022
|
Exodus Point Capital Management, LP
New York, NY |
SELL
|
- |
-163KClosed |
$200K - $321K
|
0
$0
|
|
|
Nov 04, 2022
Q3 2022
|
Russell Investments Group, Ltd.
|
SELL
|
- |
-174K- 73.96% |
$214K - $343K
|
61.3K
$51.5K
|
|
|
Nov 10, 2022
Q3 2022
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-217K- 54.54% |
$266K - $427K
|
181K
$152K
|
|
|
Nov 14, 2022
Q3 2022
|
Newtyn Management, LLC
New York, NY |
SELL
|
- |
-273K- 25.47% |
$336K - $539K
|
800K
$672K
|
|
|
Nov 14, 2022
Q3 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-287K- 85.37% |
$353K - $565K
|
49.2K
$41.3K
|
|
|
Nov 14, 2022
Q3 2022
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-540K- 10.64% |
$665K - $1.06M
|
4.54M
$3.81M
|
|
|
Nov 14, 2022
Q3 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-909K- 63.06% |
$1.12M - $1.79M
|
533K
$447K
|